SEARCH

SEARCH BY CITATION

References

  • 1
    Pisani P, Parkin DM, Bray F et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer 1999; 83: 1829.
  • 2
    Kubota H, Kotoh T, Masunaga R et al. Impact of screening survey of gastric cancer on clinicopathological features and survival: retrospective study at a single institution. Surgery 2000; 128: 417.
  • 3
    Whiting JL, Sigurdsson A, Rowlands DC et al. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut 2002; 50: 37881.
  • 4
    Dan YY, So JB, Yeoh KG. Endoscopic screening for gastric cancer. Clin. Gastroenterol. Hepatol. 2006; 4: 70916.
  • 5
    Moretó M. Diagnosis of esophagogastric tumors. Endoscopy 2005; 37: 2632.
  • 6
    Sugano K, Sato K, Yao K. New diagnostic approaches for early detection of gastric cancer. Dig. Dis. 2004; 22: 32733.
  • 7
    Yeoh KG, Salto-Tellez M, Khor CJ, Shah N, Ho KY. Confocal laser endoscopy is useful for in-vivo rapid diagnosis of gastric neoplasia and pre-neoplasia. Gastroenterology 2005; 128 (Suppl. 2): A27A27.
  • 8
    So JBY, Yeoh KG, Moochala S et al. Serum pepsinogen levels in gastric cancer patients and their relationship with Helicobacter infection: a prospective study. Gastric Cancer 2002; 5:22832.
  • 9
    El-Omar EM, Carrington M, Chow WH et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398402.
  • 10
    Wu MS, Wu CY, Chen CJ, Lin MT, Shun CT, Lin JT. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int. J. Cancer 2003; 104: 61723.
  • 11
    Lu W, Pan K, Zhang L, Lin D, Miao X, You W. Genetic polymorphisms of interleukin (IL) -1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis 2005; 26: 6316.
  • 12
    Poon TC, Sung JJ, Chow SM et al. Diagnosis of gastric cancer by serum proteomic fingerprinting. Gastroenterology 2006; 130: 185864.
  • 13
    Yasui W, Oue N, Ito R, Kuraoka K, Nakayama H. Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications. Cancer Sci. 2004; 95: 38592.
  • 14
    Graham DY, Shiotani A. The time to eradicate gastric cancer is now. Gut 2005; 54: 7358.
  • 15
    Wong BCY, Lam SK, Wong WM et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 18794.
  • 16
    Brennan MF. Current status of surgery for gastric cancer: a review. Gastric Cancer 2005; 8: 6470.
  • 17
    Ohtsu A. Current status and future prospects of chemotherapy for metastatic gastric cancer: a review. Gastric Cancer 2005; 8: 95102.
  • 18
    Ichikawa W, Takahashi T, Suto K et al. Simple combinations of 5-FU pathway genes predict the outcome of metastatic gastric cancer patients treated by S-1. Int. J. Cancer 2006; 119: 192733.
  • 19
    Mimori K, Sadanaga N, Yoshikawa Y et al. Reduced tau expression in gastric cancer can identify candidates for successful Paclitaxel treatment. Br. J. Cancer 2006; 94: 18947.
  • 20
    Ruzzo A, Graziano F, Kawakami K et al. Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy. J. Clin. Oncol. 2006; 24: 188391.
  • 21
    Zheng L, Wang L, Ajani J, Xie K. Molecular basis of gastric cancer development and progression. Gastric Cancer 2004; 7: 6177.
  • 22
    Guilford P, Hopkins J, Harraway J et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392: 4025.
  • 23
    Li Q-L, Ito K, Sakakura C et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002; 109: 11324.
  • 24
    Ito K, Liu Q, Salto-Tellez M et al. RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Cancer Res. 2005; 65: 774350.
  • 25
    Fondevila C, Metges JP, Fuster J et al. P53 and VEGF expression are independent predictors of tumor recurrence and survival following curative resection of gastric cancer. Br. J. Cancer 2004; 90: 20615.